254 related articles for article (PubMed ID: 9530221)
21. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells.
Feng Y; Venema VJ; Venema RC; Tsai N; Caldwell RB
Biochem Biophys Res Commun; 1999 Mar; 256(1):192-7. PubMed ID: 10066445
[TBL] [Abstract][Full Text] [Related]
22. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
Wang J; Morita I; Onodera M; Murota SI
J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
[TBL] [Abstract][Full Text] [Related]
24. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries.
Laitinen M; Zachary I; Breier G; Pakkanen T; Häkkinen T; Luoma J; Abedi H; Risau W; Soma M; Laakso M; Martin JF; Ylä-Herttuala S
Hum Gene Ther; 1997 Oct; 8(15):1737-44. PubMed ID: 9358023
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium.
Morbidelli L; Chang CH; Douglas JG; Granger HJ; Ledda F; Ziche M
Am J Physiol; 1996 Jan; 270(1 Pt 2):H411-5. PubMed ID: 8769777
[TBL] [Abstract][Full Text] [Related]
26. Effects of coronary artery disease on expression and microvascular response to VEGF.
Métais C; Li J; Li J; Simons M; Sellke FW
Am J Physiol; 1998 Oct; 275(4):H1411-8. PubMed ID: 9746492
[TBL] [Abstract][Full Text] [Related]
27. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide.
Breslin JW; Pappas PJ; Cerveira JJ; Hobson RW; Durán WN
Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H92-H100. PubMed ID: 12388327
[TBL] [Abstract][Full Text] [Related]
28. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A
Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
Papapetropoulos A; García-Cardeña G; Madri JA; Sessa WC
J Clin Invest; 1997 Dec; 100(12):3131-9. PubMed ID: 9399960
[TBL] [Abstract][Full Text] [Related]
30. The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats.
Heba G; Krzemiński T; Porc M; Grzyb J; Ratajska A; Dembińska-Kieć A
J Vasc Res; 2001; 38(3):288-300. PubMed ID: 11399901
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor causes pulmonary vasodilation through activation of the phosphatidylinositol-3-kinase-nitric oxide pathway in the late-gestation ovine fetus.
Grover TR; Zenge JP; Parker TA; Abman SH
Pediatr Res; 2002 Dec; 52(6):907-12. PubMed ID: 12438669
[TBL] [Abstract][Full Text] [Related]
32. Endogenous production of nitric oxide by vascular endothelial growth factor down-regulates proliferation of choriocarcinoma cells.
Cha MS; Lee MJ; Je GH; Kwak JY
Biochem Biophys Res Commun; 2001 Apr; 282(4):1061-6. PubMed ID: 11352660
[TBL] [Abstract][Full Text] [Related]
33. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells.
Tran J; Rak J; Sheehan C; Saibil SD; LaCasse E; Korneluk RG; Kerbel RS
Biochem Biophys Res Commun; 1999 Nov; 264(3):781-8. PubMed ID: 10544009
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells.
Sone H; Deo BK; Kumagai AK
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1876-84. PubMed ID: 10845612
[TBL] [Abstract][Full Text] [Related]
35. VEGF induces NO-dependent hyperpermeability in coronary venules.
Wu HM; Huang Q; Yuan Y; Granger HJ
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2735-9. PubMed ID: 8997338
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
Suzuma K; Takagi H; Otani A; Honda Y
Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483
[TBL] [Abstract][Full Text] [Related]
37. VEGF modulates NO production: the basis of a cytoprotective effect?
Servos S; Zachary I; Martin JF
Cardiovasc Res; 1999 Mar; 41(3):509-10. PubMed ID: 10435021
[No Abstract] [Full Text] [Related]
38. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells.
Hangai M; Murata T; Miyawaki N; Spee C; Lim JI; He S; Hinton DR; Ryan SJ
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1617-25. PubMed ID: 11381069
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries.
Ku DD; Zaleski JK; Liu S; Brock TA
Am J Physiol; 1993 Aug; 265(2 Pt 2):H586-92. PubMed ID: 8368362
[TBL] [Abstract][Full Text] [Related]
40. The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein.
Broeders MA; Doevendans PA; Maessen JG; van Gorsel E; Egbrink MG; Daemen MJ; Tangelder GJ; Reneman RS; van der Zee R
J Thorac Cardiovasc Surg; 2001 Aug; 122(2):305-9. PubMed ID: 11479503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
